(adsbygoogle = window.adsbygoogle || []).push({});

NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces that the Company has entered…

Continue ReadingNovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023

SMC Research revoit à la hausse l'attribution de NAGA au niveau « ACHAT spéculatif » avec un important potentiel haussier sur fond de fusion imminente avec Capex.com

HAMBOURG, Allemagne--(BUSINESS WIRE)--Les analystes de SMC Research recommandent dans leur dernier rapport d'étude sur The NAGA GROUP (XETRA : N4G, ISIN : DE000A161NR7), fournisseur de…

Continue ReadingSMC Research revoit à la hausse l'attribution de NAGA au niveau « ACHAT spéculatif » avec un important potentiel haussier sur fond de fusion imminente avec Capex.com

Riassunto: SMC Research aggiorna NAGA ad “ACQUISTO speculativo” con notevole potenziale di crescita al seguito dell'imminente fusione con Capex.com

AMBURGO, Germania--(BUSINESS WIRE)--Nel rapporto del loro ultimo studio svolto su The NAGA GROUP (XETRA: N4G, ISIN: DE000A161NR7), fornitore di NAGA, la super app finanziaria tutto…

Continue ReadingRiassunto: SMC Research aggiorna NAGA ad “ACQUISTO speculativo” con notevole potenziale di crescita al seguito dell'imminente fusione con Capex.com
Enjoying Merger Arbitrage Limited?

Enjoying Merger Arbitrage Limited?

Sign up then! It's quick and FREE

Have time to share an article? It's very much appreciated!!

You have Successfully Subscribed!